Azizi Gholamreza, Yazdani Reza, Hamid Kabir Magaji, Razavi Alireza, Mirshafiey Abbas
Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran-14155, Box: 6446, Iran.
Endocr Metab Immune Disord Drug Targets. 2015;15(3):242-50. doi: 10.2174/1871530315666150331154733.
Idiopathic thrombocytopenic purpura (ITP) as an autoimmune disease is identified by low count platelet due to decreaed platelet production as well as increased platelet destruction by autoimmune mechanisms in which platelet autoantigen(s) react with the patient's immune system. In ITP a shift toward B cells producing autoantibodies together with CD4+ T helper cells have been reported. T helper cell 22 (Th22) as a new subset of CD4+ T cells is distinctly apart from Th17 and other known CD4+ T cell subsets due to the expression of its specific gene and function. Th22 subset show chemokine receptor CCR4+ CCR6+ CCR10+ phenotype and its key transcription factor is aryl hydrocarbon receptor (AHR). In addition, Th22 cells can be recognized by secretion of a distinguished profile of effector cytokines, including interleukin (IL)- 22, IL- 13, and tumor necrosis factor-α (TNF-α). The amount of Th22 and IL-22 is increased in several autoimmune disorders and positively related to disease severity. The purpose of the present review is to discuss the role of Th22 and its cytokine IL-22 in the immunopathogenesis of ITP.
特发性血小板减少性紫癜(ITP)作为一种自身免疫性疾病,其特征是血小板计数低,这是由于血小板生成减少以及自身免疫机制导致血小板破坏增加,在自身免疫机制中血小板自身抗原与患者的免疫系统发生反应。在ITP中,已报道存在向产生自身抗体的B细胞与CD4 +辅助性T细胞转变的情况。辅助性T细胞22(Th22)作为CD4 + T细胞的一个新亚群,由于其特定基因的表达和功能,与Th17及其他已知的CD4 + T细胞亚群明显不同。Th22亚群表现出趋化因子受体CCR4 + CCR6 + CCR10 +表型,其关键转录因子是芳烃受体(AHR)。此外,Th22细胞可通过分泌包括白细胞介素(IL)-22、IL-13和肿瘤坏死因子-α(TNF-α)在内的一组独特效应细胞因子来识别。在几种自身免疫性疾病中,Th22和IL-22的量增加,且与疾病严重程度呈正相关。本综述的目的是讨论Th22及其细胞因子IL-22在ITP免疫发病机制中的作用。